Articles

This session will target the healthcare system's ability to transform from within.

Dr. Jeffrey Scott will present the results of the Integra Connect Report on OCM.

Community cancer care remains at the central core for delivering cancer care at local levels. Community oncology model continues to be proven as a sustained effective industry leader in cost control while delivering high-value cancer care service. With that said there are many incongruences between the economic models of community and large cancer centers in terms of scale, technology, drug cost, and contracting with payers.

While there are only two sides to the cost-benefit equation, each has a number of components baked in. On the cost side, increasingly sophisticated cell-based and other immunotherapies can be expensive to manufacture and deliver, and supportive and other resource-based care costs incurred by providers must also be factored in.

The opportunity is now to transform the U.S. healthcare system. We pay vastly more for healthcare than the world’s other 10 most industrialized nations, and yet, our quality outcomes are at the bottom of the list. We’re last in life expectancy, childhood mortality and maternal mortality. Hundreds of thousands of people die prematurely each year from medical error, omissions in prevention and avoidable complications from chronic disease.

The executive leadership of the most prominent industry influencers in cancer care will engage in discussions outlining their strategic initiatives and on common ground issues ahead.

Blair Childs will discuss Washington policy implications for this transformational time in healthcare.

Fox Business Host, Larry Kudlow will discuss healthcare economics.

Washington and State public policy and legislative actions impact the cancer care market greater than any other health payer group, as 50% in Medicare and 10% under Medicaid coverage. The administration has pushed thru new positive legislative policies changes that have paved the way for value-based agreements and innovation in the financing of healthcare.

Access to the cancer care system and all the resources available that are desperately needed by family, caregivers, and patients remains extremely difficult to navigate. This panel of advocacy experts will help us better understand impactful ways for us to do better.